Recent Finacing
Recent Raise
Signatope develops antibody-based biomarker assays that detect and quantify organ-damage and drug-interaction biomarkers in blood, urine, and tissue to enable early detection of adverse effects during drug development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor